| 3.2 |
9.6 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 2.8 |
14.2 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 2.8 |
8.4 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 2.6 |
7.8 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 2.5 |
7.4 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 2.3 |
7.0 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.2 |
6.7 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.2 |
10.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.1 |
8.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 2.1 |
6.3 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 2.0 |
6.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 2.0 |
6.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.9 |
5.7 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 1.9 |
9.3 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.8 |
9.2 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.8 |
9.2 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 1.8 |
7.3 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.8 |
1.8 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.8 |
7.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 1.7 |
5.2 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.7 |
5.2 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.7 |
5.2 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 1.7 |
5.1 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.7 |
3.3 |
GO:1904347 |
intestine smooth muscle contraction(GO:0014827) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) regulation of small intestine smooth muscle contraction(GO:1904347) small intestine smooth muscle contraction(GO:1990770) |
| 1.7 |
21.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.6 |
14.8 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 1.6 |
4.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 1.6 |
4.8 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 1.6 |
11.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 1.6 |
4.7 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.6 |
4.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.6 |
4.7 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.5 |
4.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.5 |
3.0 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.5 |
5.9 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.4 |
1.4 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 1.4 |
4.3 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 1.4 |
4.3 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.4 |
5.7 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.4 |
5.6 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.4 |
2.7 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 1.3 |
4.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.3 |
1.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 1.3 |
4.0 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.3 |
7.9 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 1.3 |
3.8 |
GO:0040010 |
positive regulation of growth rate(GO:0040010) |
| 1.3 |
1.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.3 |
3.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 1.2 |
5.0 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.2 |
3.7 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 1.2 |
3.7 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 1.2 |
8.6 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.2 |
4.9 |
GO:1902340 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.2 |
3.7 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 1.2 |
3.7 |
GO:0016132 |
brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 1.2 |
9.8 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.2 |
3.6 |
GO:2000510 |
positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.2 |
13.2 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.2 |
2.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.2 |
3.6 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.2 |
4.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 1.2 |
3.5 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 1.2 |
8.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.2 |
2.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 1.1 |
3.4 |
GO:0060468 |
prevention of polyspermy(GO:0060468) |
| 1.1 |
8.0 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.1 |
5.7 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 |
7.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 1.1 |
3.4 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 1.1 |
5.5 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 1.1 |
1.1 |
GO:0003195 |
tricuspid valve formation(GO:0003195) |
| 1.1 |
1.1 |
GO:2000331 |
regulation of terminal button organization(GO:2000331) |
| 1.1 |
3.3 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 1.1 |
4.4 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 1.1 |
3.2 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 1.1 |
9.5 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 1.1 |
3.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.1 |
5.3 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 1.0 |
3.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 1.0 |
6.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 |
5.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.0 |
3.0 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 1.0 |
4.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 1.0 |
4.0 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.0 |
4.0 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 1.0 |
3.0 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.0 |
3.0 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.0 |
4.0 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.0 |
4.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.0 |
2.9 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 1.0 |
3.9 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 1.0 |
1.0 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 1.0 |
2.9 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.0 |
1.0 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 1.0 |
6.8 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.0 |
1.0 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.0 |
4.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.0 |
10.6 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.0 |
1.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.0 |
3.8 |
GO:0021648 |
vestibulocochlear nerve morphogenesis(GO:0021648) |
| 1.0 |
3.8 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.9 |
3.8 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.9 |
3.8 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.9 |
6.6 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.9 |
2.8 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.9 |
7.4 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.9 |
0.9 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.9 |
2.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 |
1.8 |
GO:0009838 |
abscission(GO:0009838) |
| 0.9 |
0.9 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.9 |
2.7 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.9 |
2.7 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.9 |
6.4 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.9 |
0.9 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.9 |
0.9 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
| 0.9 |
2.7 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.9 |
1.8 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.9 |
13.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.9 |
1.8 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.9 |
2.7 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.9 |
2.7 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.9 |
0.9 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.9 |
2.6 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.9 |
2.6 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.9 |
0.9 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.9 |
2.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.9 |
0.9 |
GO:0071864 |
positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.9 |
2.6 |
GO:0060129 |
thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.9 |
2.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 |
1.7 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.9 |
6.0 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.8 |
2.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.8 |
3.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.8 |
1.7 |
GO:2000017 |
regulation of determination of dorsal identity(GO:2000015) positive regulation of determination of dorsal identity(GO:2000017) |
| 0.8 |
2.5 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.8 |
5.8 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.8 |
0.8 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.8 |
1.7 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.8 |
9.9 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.8 |
4.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.8 |
0.8 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.8 |
4.9 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.8 |
0.8 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.8 |
1.6 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.8 |
3.2 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.8 |
4.0 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.8 |
2.4 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.8 |
0.8 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.8 |
0.8 |
GO:0045627 |
positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.8 |
7.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.8 |
0.8 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.8 |
2.3 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.8 |
1.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.8 |
4.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.8 |
0.8 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.8 |
3.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.8 |
1.5 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.8 |
1.5 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 0.8 |
3.8 |
GO:0009189 |
deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
| 0.8 |
6.9 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.8 |
1.5 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.8 |
2.3 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.7 |
0.7 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.7 |
1.5 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.7 |
0.7 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.7 |
0.7 |
GO:0060043 |
regulation of cardiac muscle cell proliferation(GO:0060043) |
| 0.7 |
0.7 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.7 |
0.7 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.7 |
0.7 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.7 |
2.9 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.7 |
0.7 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 |
8.7 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.7 |
2.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.7 |
1.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.7 |
1.4 |
GO:0086053 |
AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.7 |
2.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.7 |
10.7 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.7 |
0.7 |
GO:0098969 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.7 |
0.7 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.7 |
2.8 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.7 |
1.4 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.7 |
1.4 |
GO:0002862 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.7 |
16.1 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.7 |
2.1 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.7 |
7.7 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.7 |
2.1 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.7 |
2.1 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.7 |
0.7 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.7 |
2.0 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.7 |
4.0 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.7 |
6.7 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.7 |
2.7 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.7 |
2.0 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.7 |
6.0 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.7 |
2.7 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.7 |
4.0 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.7 |
6.6 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.7 |
0.7 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.6 |
3.9 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.6 |
0.6 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 |
3.2 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.6 |
1.9 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.6 |
20.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.6 |
8.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 |
1.3 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.6 |
4.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.6 |
2.5 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.6 |
3.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.6 |
5.0 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.6 |
2.5 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 |
1.2 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.6 |
3.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.6 |
1.2 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.6 |
1.9 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.6 |
1.2 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.6 |
3.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
0.6 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.6 |
4.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.6 |
3.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.6 |
3.7 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.6 |
3.0 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.6 |
4.3 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.6 |
6.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.6 |
3.6 |
GO:0046490 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.6 |
4.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.6 |
3.5 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.6 |
1.8 |
GO:0060375 |
regulation of mast cell differentiation(GO:0060375) |
| 0.6 |
5.2 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.6 |
2.3 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 |
3.5 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.6 |
3.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.6 |
6.8 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.6 |
2.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.6 |
2.8 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.6 |
1.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.6 |
1.7 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.6 |
9.6 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.6 |
4.5 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.6 |
2.8 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.6 |
0.6 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 0.6 |
1.1 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.6 |
2.2 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.6 |
1.7 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.6 |
12.2 |
GO:0032986 |
protein-DNA complex disassembly(GO:0032986) |
| 0.6 |
1.7 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.6 |
3.9 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.5 |
2.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.5 |
2.2 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.5 |
1.6 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.5 |
1.6 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.5 |
2.7 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.5 |
2.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.5 |
1.1 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.5 |
2.2 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.5 |
1.1 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 0.5 |
0.5 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.5 |
1.6 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.5 |
0.5 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.5 |
1.6 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) regulation of testosterone secretion(GO:2000843) |
| 0.5 |
1.1 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.5 |
1.6 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.5 |
1.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.5 |
3.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.5 |
7.5 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.5 |
1.6 |
GO:2000016 |
negative regulation of determination of dorsal identity(GO:2000016) |
| 0.5 |
2.7 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
5.9 |
GO:0048617 |
embryonic foregut morphogenesis(GO:0048617) |
| 0.5 |
2.1 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.5 |
7.4 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.5 |
1.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 |
3.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 |
1.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
4.1 |
GO:0001916 |
regulation of T cell mediated cytotoxicity(GO:0001914) positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.5 |
10.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.5 |
4.1 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.5 |
1.0 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.5 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.5 |
1.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.5 |
5.1 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.5 |
1.5 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.5 |
0.5 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.5 |
2.5 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.5 |
1.0 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.5 |
7.5 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.5 |
1.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.5 |
8.0 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.5 |
1.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.5 |
2.0 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 |
3.0 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 |
2.5 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
2.5 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.5 |
4.0 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.5 |
3.0 |
GO:0046512 |
sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.5 |
1.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.5 |
1.0 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.5 |
1.5 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.5 |
1.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
5.4 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 |
2.0 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.5 |
1.5 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.5 |
0.5 |
GO:0098964 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.5 |
2.4 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 |
2.4 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.5 |
2.4 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.5 |
2.4 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.5 |
2.4 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.5 |
1.0 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.5 |
5.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.5 |
1.9 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 |
0.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.5 |
0.9 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
0.5 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.5 |
2.8 |
GO:2001171 |
positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.5 |
4.2 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.5 |
0.5 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.5 |
0.9 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.5 |
2.8 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.5 |
1.4 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.5 |
0.9 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.5 |
1.4 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.5 |
0.9 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.5 |
1.8 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.5 |
2.3 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.5 |
0.9 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.5 |
1.8 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.5 |
0.5 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.5 |
0.5 |
GO:0080144 |
amino acid homeostasis(GO:0080144) |
| 0.5 |
2.3 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.5 |
2.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.4 |
0.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.4 |
0.4 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.4 |
0.4 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.4 |
0.9 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.3 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
3.6 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.4 |
1.8 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
0.9 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.4 |
3.5 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.4 |
1.3 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 |
1.7 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 |
1.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.4 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 |
0.9 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.4 |
4.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 |
0.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.4 |
5.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.4 |
3.0 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.4 |
2.6 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
2.1 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.4 |
0.4 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.4 |
0.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
0.4 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.4 |
0.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.4 |
1.3 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.4 |
0.8 |
GO:0051461 |
corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.4 |
4.6 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.4 |
0.8 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.4 |
0.8 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.4 |
2.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 |
1.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 |
1.7 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.4 |
7.0 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.4 |
0.4 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.4 |
0.4 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.4 |
11.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.4 |
9.1 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.4 |
2.9 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.4 |
2.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.4 |
1.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.4 |
3.7 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.4 |
0.4 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.4 |
2.5 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.4 |
1.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.4 |
8.5 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.4 |
2.0 |
GO:0046549 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.4 |
1.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.4 |
0.8 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.4 |
1.6 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.4 |
0.4 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.4 |
1.6 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.4 |
2.8 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 |
2.0 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.4 |
10.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.4 |
1.2 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.4 |
1.2 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.4 |
0.4 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.4 |
0.4 |
GO:0072075 |
metanephric mesenchyme development(GO:0072075) |
| 0.4 |
1.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.4 |
0.8 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.4 |
0.8 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.4 |
2.8 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.4 |
0.8 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.4 |
0.8 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.4 |
1.6 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 |
2.4 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.4 |
0.8 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.4 |
1.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.4 |
1.2 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.4 |
2.7 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.4 |
4.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 |
0.4 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.4 |
1.9 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.4 |
1.2 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.4 |
1.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.4 |
0.8 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.4 |
1.9 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.4 |
0.8 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.4 |
7.6 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.4 |
1.5 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.4 |
1.9 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 |
1.1 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.4 |
2.6 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.4 |
20.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.4 |
0.4 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.4 |
3.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.4 |
1.9 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.4 |
2.2 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.4 |
4.5 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.4 |
2.2 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.4 |
1.9 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.4 |
1.8 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.4 |
0.7 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.4 |
0.7 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 |
2.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
1.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.4 |
3.3 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.4 |
1.5 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 |
1.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.4 |
3.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
0.4 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.4 |
0.7 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.4 |
1.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 |
4.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
3.6 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) |
| 0.4 |
4.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.4 |
1.4 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.4 |
0.7 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.4 |
4.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
0.4 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 |
2.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.3 |
0.7 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 |
1.0 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.3 |
1.4 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.3 |
3.1 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.3 |
2.8 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
1.0 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.3 |
1.0 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.3 |
0.3 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.3 |
1.0 |
GO:0019659 |
fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
2.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
1.0 |
GO:0019062 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
1.0 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 |
1.7 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
0.3 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.3 |
0.7 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
2.0 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
0.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.3 |
3.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
0.7 |
GO:1902256 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.3 |
1.3 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.3 |
0.3 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.3 |
0.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.3 |
4.3 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.3 |
1.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
0.3 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.3 |
0.3 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.3 |
3.7 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
0.7 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
0.7 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.3 |
1.3 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.3 |
1.0 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
11.1 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.3 |
0.7 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
0.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 |
1.3 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.3 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
2.9 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.3 |
2.6 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 |
1.0 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.3 |
1.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.3 |
0.6 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.3 |
7.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.3 |
1.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.3 |
0.3 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.3 |
4.1 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.3 |
1.6 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.3 |
2.8 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.3 |
0.3 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 |
2.2 |
GO:0098707 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.3 |
0.3 |
GO:0060699 |
regulation of endoribonuclease activity(GO:0060699) |
| 0.3 |
0.9 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.3 |
0.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.3 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.3 |
0.3 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.3 |
1.5 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.3 |
1.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.3 |
0.9 |
GO:1903538 |
meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.3 |
0.9 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.3 |
1.8 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.3 |
1.2 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.3 |
2.1 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.3 |
0.9 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.3 |
0.3 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.3 |
0.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 |
0.6 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.3 |
1.8 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.3 |
2.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.3 |
4.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
2.4 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.3 |
1.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.3 |
0.3 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.3 |
1.8 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.3 |
0.9 |
GO:0051309 |
female meiosis chromosome separation(GO:0051309) |
| 0.3 |
1.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.3 |
0.3 |
GO:0061724 |
lipophagy(GO:0061724) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.3 |
0.9 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.3 |
1.7 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.3 |
1.2 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 |
1.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 |
0.6 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 |
2.8 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.3 |
0.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
1.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.3 |
0.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.3 |
0.8 |
GO:1902218 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
| 0.3 |
0.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 |
0.6 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.3 |
13.2 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.3 |
0.3 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
0.8 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.3 |
0.8 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 |
1.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
2.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
2.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.3 |
0.6 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
1.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 |
11.7 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
2.5 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.3 |
0.8 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.3 |
1.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.3 |
1.7 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.3 |
2.7 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.3 |
0.3 |
GO:0042368 |
negative regulation of vitamin D biosynthetic process(GO:0010957) vitamin D biosynthetic process(GO:0042368) negative regulation of vitamin metabolic process(GO:0046137) regulation of vitamin D biosynthetic process(GO:0060556) |
| 0.3 |
0.5 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 |
7.1 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.3 |
0.3 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.3 |
2.7 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
1.1 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.3 |
1.4 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
| 0.3 |
4.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.3 |
1.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.3 |
1.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
1.4 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.3 |
1.3 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.3 |
1.1 |
GO:0071073 |
positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.3 |
1.1 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.3 |
4.3 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.3 |
3.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.3 |
1.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
2.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 |
0.5 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 |
0.5 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.3 |
1.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
1.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.3 |
0.3 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.3 |
2.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
1.0 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.3 |
1.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.3 |
0.5 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.3 |
0.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
0.5 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 |
2.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
1.5 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.3 |
0.3 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.3 |
1.8 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.3 |
0.5 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.3 |
3.5 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 |
3.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
0.5 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
2.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
1.5 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.2 |
3.7 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
4.4 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 |
0.5 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.2 |
0.2 |
GO:1904809 |
dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.2 |
1.5 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.2 |
0.5 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 |
0.5 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.2 |
1.5 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.2 |
1.2 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.2 |
2.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
1.7 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
0.7 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.2 |
1.4 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
1.0 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
1.9 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.2 |
2.9 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.2 |
1.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
0.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 |
0.2 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.2 |
0.5 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.2 |
0.2 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.2 |
0.5 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 |
4.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.2 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
1.2 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
2.8 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 |
1.6 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.2 |
4.4 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.2 |
1.4 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 |
0.5 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 |
0.5 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.2 |
0.7 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
1.4 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.2 |
0.7 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.2 |
0.5 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
1.2 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.2 |
0.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.2 |
0.9 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.2 |
1.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.5 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.2 |
1.6 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 |
3.6 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.2 |
0.7 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
0.7 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
0.2 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
0.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
0.7 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 |
1.3 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
0.7 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.2 |
1.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
0.7 |
GO:0034035 |
sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.2 |
1.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
0.4 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.2 |
0.6 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
1.1 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
0.2 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.2 |
0.9 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
1.5 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
2.8 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.2 |
0.4 |
GO:0035523 |
protein K29-linked deubiquitination(GO:0035523) |
| 0.2 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
1.1 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
0.6 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
1.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.2 |
1.5 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
1.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.2 |
0.4 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.2 |
0.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
1.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.2 |
1.7 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.2 |
1.7 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.2 |
0.8 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
0.4 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.2 |
3.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
0.4 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
2.9 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.2 |
0.4 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.2 |
2.0 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
0.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
0.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 |
1.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.2 |
0.8 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
1.2 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.2 |
1.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.2 |
0.8 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.2 |
1.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.6 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.2 |
0.8 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
0.4 |
GO:0003347 |
epicardial cell to mesenchymal cell transition(GO:0003347) |
| 0.2 |
0.6 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 |
0.6 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.2 |
6.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
3.8 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
2.7 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 |
0.4 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.2 |
7.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
0.8 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
0.6 |
GO:0046471 |
cardiolipin metabolic process(GO:0032048) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.2 |
4.0 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 |
0.6 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
1.7 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 |
0.9 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.7 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
1.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 |
1.3 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.2 |
0.4 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.2 |
1.3 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
1.1 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.2 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
1.3 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
0.7 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
1.3 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.2 |
1.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 |
0.5 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
7.6 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.2 |
1.6 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
0.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.2 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
0.9 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 |
0.5 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.2 |
2.0 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.2 |
3.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
0.5 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.5 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 |
4.2 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.2 |
1.2 |
GO:0070474 |
uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.2 |
0.7 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.2 |
0.3 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.3 |
GO:0021626 |
hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
| 0.2 |
0.3 |
GO:2000209 |
regulation of anoikis(GO:2000209) |
| 0.2 |
0.3 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.2 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.2 |
1.6 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.9 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
1.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
0.7 |
GO:1902165 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.2 |
0.7 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 |
2.2 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 |
1.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.5 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
1.5 |
GO:0051900 |
regulation of mitochondrial depolarization(GO:0051900) |
| 0.2 |
0.3 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 |
1.2 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 0.2 |
0.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.2 |
1.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.2 |
0.7 |
GO:1901984 |
negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) |
| 0.2 |
0.5 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.2 |
1.0 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.2 |
0.3 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 |
0.3 |
GO:0060479 |
lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.2 |
1.2 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.2 |
1.0 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
1.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
2.8 |
GO:1902235 |
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.2 |
0.8 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
0.7 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
0.3 |
GO:0006659 |
phosphatidylserine metabolic process(GO:0006658) phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
0.3 |
GO:1902186 |
regulation of viral release from host cell(GO:1902186) |
| 0.2 |
3.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
1.8 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.2 |
2.1 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
0.2 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.2 |
0.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
2.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 |
9.6 |
GO:0048024 |
regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.2 |
0.3 |
GO:0080184 |
response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.2 |
2.1 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.2 |
0.2 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.2 |
0.2 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.2 |
0.5 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.2 |
4.7 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 |
1.6 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
0.3 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.2 |
0.5 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.2 |
0.6 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) regulation of cholesterol import(GO:0060620) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) regulation of sterol import(GO:2000909) positive regulation of sterol import(GO:2000911) |
| 0.2 |
1.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.6 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
2.2 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.2 |
2.8 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
0.6 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.2 |
0.2 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.2 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
0.2 |
GO:0045575 |
basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.2 |
0.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.2 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.2 |
0.6 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
1.4 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
0.5 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.4 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.1 |
0.7 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.6 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
1.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
0.7 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.4 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.1 |
0.3 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
6.0 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
4.9 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.4 |
GO:0048308 |
organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
| 0.1 |
0.7 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
1.0 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
1.7 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.7 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.4 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.6 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.9 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.3 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.6 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
1.0 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.7 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.3 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
1.6 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
1.1 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 |
2.3 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
1.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.5 |
GO:0046103 |
inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.1 |
0.7 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 |
0.4 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.1 |
0.4 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 |
3.3 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.9 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 |
2.1 |
GO:0033865 |
coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.1 |
0.5 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 |
0.1 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.1 |
0.5 |
GO:0042501 |
serine phosphorylation of STAT protein(GO:0042501) |
| 0.1 |
0.4 |
GO:0019389 |
glucuronoside metabolic process(GO:0019389) |
| 0.1 |
1.6 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 |
0.4 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.6 |
GO:0031034 |
myosin filament assembly(GO:0031034) |
| 0.1 |
0.3 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
0.9 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
0.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.9 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
2.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.6 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
1.1 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
0.3 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.2 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
7.6 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.1 |
0.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.1 |
0.4 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
3.2 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.1 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
1.6 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
3.7 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.4 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
1.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
4.1 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
0.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
1.2 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.7 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.1 |
1.1 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.1 |
1.4 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
1.4 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.8 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.1 |
0.2 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
0.8 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
3.5 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.8 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.8 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) |
| 0.1 |
0.1 |
GO:0000820 |
regulation of glutamine family amino acid metabolic process(GO:0000820) regulation of glutamate metabolic process(GO:2000211) |
| 0.1 |
0.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.8 |
GO:0033630 |
positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.1 |
1.0 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
2.0 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.1 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.7 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.9 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.7 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.5 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.3 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
1.0 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.8 |
GO:0003044 |
regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
| 0.1 |
0.2 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.1 |
0.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.5 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
1.4 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
0.2 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.2 |
GO:0051293 |
establishment of spindle localization(GO:0051293) |
| 0.1 |
8.1 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.1 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
0.3 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
1.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.1 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.1 |
0.6 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.3 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 |
0.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 |
0.3 |
GO:1903936 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) cellular response to sodium arsenite(GO:1903936) |
| 0.1 |
0.1 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
0.7 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.4 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.6 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.3 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.5 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
1.3 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.1 |
2.3 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.1 |
0.6 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.8 |
GO:0070874 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.3 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.9 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.1 |
0.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.2 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.1 |
0.1 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
1.7 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 |
0.3 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.2 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 |
1.0 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
1.6 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.6 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.8 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.2 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.1 |
0.4 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.1 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.1 |
0.1 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.1 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.6 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.1 |
0.8 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
0.2 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.1 |
0.1 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.1 |
0.3 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
0.4 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.1 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
1.0 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.0 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.7 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
2.9 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.3 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.1 |
0.3 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.5 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.1 |
0.2 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.9 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.1 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 |
0.3 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.1 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.2 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.1 |
2.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.6 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.1 |
0.3 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.1 |
0.2 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
1.7 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.2 |
GO:0033007 |
negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of leukocyte degranulation(GO:0043301) |
| 0.1 |
0.6 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.2 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.2 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.5 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.3 |
GO:1903028 |
regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.1 |
0.8 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
1.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
0.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.4 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
1.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.8 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
0.1 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
0.4 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.1 |
0.3 |
GO:0014820 |
tonic smooth muscle contraction(GO:0014820) |
| 0.1 |
0.1 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
1.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
1.3 |
GO:0002092 |
positive regulation of receptor internalization(GO:0002092) |
| 0.1 |
0.3 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.2 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.3 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.1 |
1.4 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.1 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 0.1 |
0.7 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.1 |
0.5 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 |
0.3 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.1 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 |
0.3 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.1 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.1 |
GO:0014063 |
serotonin secretion(GO:0001820) regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.2 |
GO:2000679 |
positive regulation of transcription regulatory region DNA binding(GO:2000679) |
| 0.1 |
0.1 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.1 |
1.5 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.3 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.5 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.3 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.6 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
1.0 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
1.2 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.1 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.1 |
0.2 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.1 |
1.1 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.1 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.5 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.1 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) positive regulation of glucagon secretion(GO:0070094) |
| 0.1 |
4.8 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.3 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.5 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.1 |
GO:0006409 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
1.3 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.1 |
0.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.4 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.9 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.1 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.1 |
0.1 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.1 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 |
0.5 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.3 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.1 |
0.2 |
GO:0071671 |
regulation of smooth muscle cell chemotaxis(GO:0071671) |
| 0.1 |
4.8 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.1 |
0.3 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 |
0.1 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.0 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 |
0.6 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.1 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.0 |
0.5 |
GO:0086067 |
AV node cell to bundle of His cell communication(GO:0086067) |
| 0.0 |
0.1 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.1 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.0 |
0.0 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.6 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 |
0.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.3 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.0 |
0.0 |
GO:1902583 |
intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
| 0.0 |
0.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.0 |
0.2 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.0 |
0.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
0.0 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 |
0.1 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.0 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.0 |
0.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
1.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.4 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.4 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.0 |
0.9 |
GO:0043039 |
tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
| 0.0 |
0.1 |
GO:0060294 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) cilium movement involved in cell motility(GO:0060294) |
| 0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.5 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.0 |
0.2 |
GO:0032366 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.4 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.3 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.2 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.2 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.0 |
0.1 |
GO:0010762 |
regulation of fibroblast migration(GO:0010762) |
| 0.0 |
0.1 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.1 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.1 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 |
0.2 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.5 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.0 |
1.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.7 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.2 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.0 |
0.0 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.5 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.1 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 |
0.1 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.0 |
0.1 |
GO:0006779 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.0 |
0.2 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.2 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.0 |
0.2 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 |
2.0 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.1 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.2 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.0 |
0.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.0 |
0.1 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.0 |
GO:0030656 |
regulation of vitamin metabolic process(GO:0030656) |
| 0.0 |
0.3 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.1 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.0 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.0 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.0 |
GO:0090004 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.0 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.0 |
0.0 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.0 |
0.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.1 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 |
0.1 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.1 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.0 |
0.1 |
GO:1902253 |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
| 0.0 |
0.1 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.0 |
0.1 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.0 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.0 |
0.0 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.0 |
0.0 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.0 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.0 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.0 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 |
0.1 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.5 |
GO:0065004 |
protein-DNA complex assembly(GO:0065004) |
